Abordagem terapêutica da hemorragia intracerebral na fase aguda

Autores

  • Francisco Silva Assistente Hospitalar de Medicina Interna, Serviço de Medicina II do Hospital Egas Moniz, Lisboa

Palavras-chave:

hemorragia intracerebral, terapêutica de fase aguda,

Resumo

A hemorragia intracerebral (HIC) corresponde a cerca de 10 a 15% das admissões hospitalares por acidente vascular cerebral, sendo mais de duas vezes mais frequente do que a hemorragia meníngea. Apresenta morbilidade e mortalidade muito elevadas, sendo maior nas primeiras horas e, por esse facto, considerada uma emergência médica. A abordagem terapêutica destes doentes tem sido alvo de muita controvérsia. Devido à ausência de estudos credíveis, randomizados, as atitudes terapêuticas não têm sido uniformes e provavelmente também não têm sido as mais correctas, com prejuízo óbvio para os doentes. Neste trabalho faz-se uma revisão da terapêutica da HJC baseada em guidelines recentes, focando os aspectos terapêuticos mais controversos, a sua etiopatogenia, as manifestações clínicas, o dia­ gnóstico e os factores de prognóstico.

Downloads

Não há dados estatísticos.

Referências

Easton JD. Hauser LS. Martin JB. Cerebrovascular Diseases. ln: Fauci AS ed,. Harrison's Principles of Internal Medicine. 14th ecl. USA: McGraw-Hill. 1998:2325-2349.

Broderick JP. Adam, HP. Barsan W et at. Guidelines for the Management of Spontaneous lntracerebral Hemorrhage. A Statement for Heathcare Professionals From a Special Writing Group of the Stroke Council. American Heart Association. Stroke 199930:905- 915.

J. Adams RD. Victor M. Ropper AH. Cerebrovascular Diseases. ln Adam, RD. Principies of Neurology. 6th ed. 1997:777-873.

Takebayashi S. Ultrastructural morphometry of hypertensive medial damage in lenticulostriate and other arteries. Stroke 1985;16:449- 453.

Anderson CS. Chakera TM . Stewart-Wynne EG. Jamrozik KD. Spectrum of primary intracerebral haemorrhage in Perth. Western Australia. 1989-90: incicdnce and outcome. J Neurol Neurosurg and Psychiatry 1994:57:936-940.

Challa V. Moody DM. Bell MA. The Charcot-Bouchard aneurysm controversy: impact of a new histologic technique. J Neurophatology Exp Neurol 1992:51 :264-271.

Wakai S, Kumakura N. Nagai M. Lobar intracerebral hemorrhage: a clinical. radiographic. and pathological study of 29 consecutive operated cases with negative angiography. J Neurosurgery 1992:76:231-238.

Vinters HV. Whisnant J. Cerebral amyloid angiopathy: a critical review. Stroke 1987: 18:311-324.

Vonsatel JP. Myers RH. Hedley-Whyte ET, Ropper AH. Birei ED, Richardson EP Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 1991 :30:637-649.

Greenberg SM, Briggs ME, Hyman BT et al. Apoprotein E e4 Is Associated With the Presence anel Earlier Onset of Hemorrhage in Cerebral Amyloid Angiopathy. Stroke 1996:27: 1333-1337.

McCarron MO. Nicoll JAR. lronside JW. et al. Cerebral Amyloid Angiopathy - Related Hemorrhage. lnteraction of APOE e2 With Putative Clinical Risk Factors. Stroke 1999:30: 1643-1646.

Broderick J. lntracerebral Hemorrhage. ln: Gorelick PB, Alter M. eds. Handbook of Neuroepidemiology. New York, NY: Marcel Dekker, lnc;l994:141-167.

Wojack JC, Flamm ES. lntracraneal hemorrhage and cocaine use. Stroke 1987:18:712-715.

He J, Whelton PK. Vu B. Klag AJ. Aspirine and Risk of Hemorrhagic Stroke. A Meta-analysis of Randomized Controlled Trials. JAMA 1998:280: 1930-1935.

Thrift AG, McNeil JJ, Forbes A. Donnan GA. Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflamatory drugs: case-control study. BMJ 1999:318:759- 764.

Colwell JÁ. Aspirin therapy in diabetes. Diabetes Care 1997:20: 1767-1771.

Baudoin C. Bousser MG. Hauguenau M. et al. Secondary prevention of Strokes: role of platelet antiaggregant drugs in diabetic and nondiabetic patients. Diabet Med 1985;2: 145-146.

Ruíz-Sandoval JL, Cantú C. Barinagarrementeria F. lntracerebral Hemorrhage in Young People. Analysis of Risk Factors. Location, Cause,. and Prognosis. Stroke l 999:30:537-541.

Gorelick PB. Hier Db, Caplan LR et al. Headache in acute cerebrovascular disease. Neurology 1986;36: 1445-1450.

Broderick J. Brott T. Tomsick T. Miller R, Huster G. lntracerebral hemorrhage is, more then twice as common as subaracnoid hemorrhage. J Neurosurg 1993:78: 188-191.

Counsell C. Boonyakarnkul.S. Dennis M, Sandercock P, Bamford J. Burn J. Warlow C. Primary intracerebral hemorrhage in the Oxfordshire community stroke project, 2: prognosis: Cerebrovasc Dis 1995;5:26-34.

Wallace Jd. Levy LL. Blood pressure after stroke. JAMA 1981 :246:2177-2180.

Mortis L, Schwartz RS, Poulo, R. Howes LG. Blood Pressure Changes in Acute Cerebral Infarction anel Hemorrhage. Stroke 1997:28: 140 l - l 405.

Brott T, Kothari R, Barsan W et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997;28: 1-5.

Tuhrim S. Blood pressure and intracerebral hemorrhage. Crit Care Med l999;27.Nº3:447-448.

Quershi AI. Bliwise DL. Bliwise NG, Akbar MS. Frankel MR. Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit Care Med 1999 Mar:27(3):480-485.

Brott T. Reed RL. lntensive care for acute stroke in the community hospital setting: the first 24 hours: Stroke 1989:20:694-697.

Rodorf G. Cramer SC. Efird JT. Schwamm LH, Buonanno F. Koroshetz WJ. Pharmacological Elevation od Blood Pressure in Acute Stroke. Clinical Effects anel Safety. Stroke 1997:28:21.B- 2 l 38.

Ropper AH. Traumatic Injuries of the Head and Spine. ln: Fauci AS eds. Harrison's, Principies of Internal Medicine. 14th ed. USA: McGraw-Hill 1998:2390-2398.

Diringer MN. lntracerebral hemorrhage: pathophisiology and management. Crit Care Med 1993;2 I: 1591-1603.

Poungvarin N, Bhoopat W, Viriyavejakul A et al. Effects of dexametasone in Primary supratentorial intracerebral hemorrhage. N Eng J Med 1987:316:1229-1233.

Batjer HH. Reisch JS. Allen BC, Paizier LJ Su CJ. Failure of surgery to improve outcome in hypertensive putaminal hemorrhage: a

prospective ranclomized triai. Arch Neuro! 1990:47:11031106.

Auer L, Deinsberger W, Niederkorn K et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg l 989;70:530-535.

McKissock W, Richardson A, Taylor J. primary intracerebral hemorrhage: a controlled trial of surgical and conservative treatment in 180 unselected cases. Lancet 1961 ;2:222-226.

Juvela S, Heiskanen O, Poranen A et al. The treatment of spontaneous, intracerebral hemorrhage: a prospective randomized triai of surgical and conservative treatment. J Neurosurg 1989;70:755-758.

Morgenster LB. FranKowski RF. Shedden P. Pasteur W. Grotta JC. Surgical treatment for intracerebral hemorrhage (STICH): a single­ center. randomized clinicai trial. Neurology 1998 Nov;51 (5 ): 1359- 1363.

Zuccarello M. Brott T. Derex L et al. Early Surgical Treatment for Supratentorial lntracerebral Hemorrhage. A Ranclomized Feasibility Study. Stroke 1999:30: 1833-1839.

Broclerick JP. Brott TG. Duldner JE et ai. Volume of intracerebral Hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke l 993;24:987-993.

Kothari RU, Brott T, Broderick JP et al. The ABC, of Measuring lntracerebral Hemorrhage Volumes. Stroke 1996;27: 1304-1305.

Zazulia AR, Diringer MN, Derdeyn CP, Powers WJ. Progression of Mass Effect After lntracerebral Hemorrhage. Stroke 1999:30: 1167- 1173.

Kazui SK. Naritomi H. Yamamoto H. Sawacla T. Yamaguchi T. Enlargement of Spontaneous lntracerebral Hemorrhage. lncidence and Time Course. Stroke l996;27:1783-1787.

Qureshi AI. Sfdar K. Weil EJ et al. Predictors os Early Deterioration anel Mortality in Black Americans With Spontaneous lntracerebral Hemorrhage. Strokc 1995;26: 1764-1767.

Fogelholm R. Avikainen S. Murros K. Prognostic Value and Determinants of First-Day Mean Aretrial Pressure in Spontaneous Supratentorial lntracerebral Hemorrhage. Stroke 1997:28: 1396-1400.

Dandapani BK, Suzuri S, Kelley RE, Reyes-lglesias Y. Duncan RC. Relation Between Blood pressure and Outcome in lntracerebral Hemorrhage. Stroke 1995:26:21-24_

Diringer MN, Edwards DF. Zazulia AR. Hydrocephalus: A Previous Unreconized Predictor of Poor Outcome From Supratentorial lntracerebral Hemorrhage. Stroke 1998; 29: 1352-1357.

_ González-Duarte A, Cantú C. Ruíz-Sandoval JL. Barinagarremente­ria F. Recurrent Primary Cerebral hemorrhage. Frequency. Mechanisms, and Prognosis. Stroke 1998;29: 1802-1805

Passero S, Burgalassi L. Dándrea P. Battistini N. Recurrence of Bleeding in Patients With Primary Intracerebral Hemorrhage. Stroke 1995:26: 1189-1192.

Arakawa S, Saku Y, lbayashi S. Nagao T, Fujishima M. Blood pressure Control and Recurrence of Hypertensive Brain Hemorrhage. Stroke 1998:29 1806-1809.

Ficheiros Adicionais

Publicado

30-06-2000

Como Citar

1.
Silva F. Abordagem terapêutica da hemorragia intracerebral na fase aguda. RPMI [Internet]. 30 de Junho de 2000 [citado 21 de Abril de 2024];7(2):101-9. Disponível em: https://revista.spmi.pt/index.php/rpmi/article/view/1987

Edição

Secção

Artigos de Revisão

Artigos Similares

Também poderá iniciar uma pesquisa avançada de similaridade para este artigo.

Artigos mais lidos do(s) mesmo(s) autor(es)